Peer Reviewed
Investigations in endocrinology

Lipid and lipoprotein testing in diabetes

David Sullivan
Abstract
When assessing cardiovascular disease risk, it may be more appropriate to be guided by the LDL-C level or, preferably, the non-HDL-C level, than the total cholesterol level.
Key Points

    Plasma lipid and lipoprotein levels affect an individual's risk of serious cardiovascular disease (CVD) events and acute pancreatitis. Endocrinologists, primary care physicians and health professionals who specialise in diabetes now require a greater level of sophistication in their understanding of lipid and lipoprotein tests. Guidelines concerning utilisation and interpretation of these tests continue to evolve.

    Picture credit: © Gary Carlson/Science Source/Diomedia.com

Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?